MedPath

Study on efficacy and characteristics of the population indicating suppression of the postprandial glucose spike with the general or health food

Not Applicable
Recruiting
Conditions
Healthy Adults
Registration Number
JPRN-UMIN000029250
Lead Sponsor
Okayama University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
140
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients diagnosed as diabetes or borderline persons who are undergoing diet, exercise or pharmacotherapy. 2) Fasting blood glucose is more than 126 mg/dL 3) HbA1c is more than 6.5% 4) Persons who are allergic to the test food 5) Persons who are taking some kind of health foods (can participate if the person withdraw its intake) 6) Persons who are pregnant or breastfeeding 7) Persons who are not taking drugs or supplements for hypertension and/or dyslipidemia (long-term exam) 8) Persons who were judged as inappropriate for subjects by the principal investigator

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Blood glucose (iGP, MAGE, iAUC)(short term) Change in HbA1c (long term)
Secondary Outcome Measures
NameTimeMethod
iAUC of postprandial blood glucose level upto 2 hours after intake. Blood pressure, serum lipids, weight etc.
© Copyright 2025. All Rights Reserved by MedPath